Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
Clinical trial NCT04672005 · UNKNOWN
Trial details
- NCT number
- NCT04672005
- Sponsor
- Lyudmyla Berim
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2024-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.